- Home
- JNJ
JNJ
Johnson & Johnson
as 12-20-2024 4:00pm EST
| Founded: | 1886 | Country: | United States |
| Employees: | N/A | City: | NEW BRUNSWICK |
| Market Cap: | N/A | IPO Year: | 1944 |
| Target Price: | $173.93 | AVG Volume (30 days): | 8.9M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 6.04 | EPS Growth: | -54.32 |
| 52 Week Low/High: | $142.75 - $168.85 | Next Earning Date: | 01-22-2025 |
| Revenue: | $87,696,000,000 | Revenue Growth: | 4.77% |
| Revenue Growth (this year): | 5.3% | Revenue Growth (next year): | 2.85% |
Latest Johnson & Johnson News
JNJ Breaking Stock News: Dive into JNJ Ticker-Specific Updates for Smart Investing
Insider Monkey
2 days ago
Is Johnson & Johnson (JNJ) a Cheap NYSE Stock to Invest in Now?
Medical Device Network
2 days ago
The 10 biggest medtech stories of 2024
Insider Monkey
3 days ago
Why Is Johnson & Johnson (JNJ) Among the Best Dividend Stocks to Invest In?
Insider Monkey
4 days ago
Jim Cramer on Johnson & Johnson (JNJ): How the Pharma Giant is Handling Billion-Dollar Lawsuits and Legal Battles
Zacks
4 days ago
SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study
BioPharma Dive
4 days ago
Tessera gets sickle cell funding; Corvus shares slide on eczema data
Motley Fool
4 days ago
The Smartest Dividend Stocks to Buy With $500 Right Now
Zacks
5 days ago
FDA Gives CRL to J&J's BLA for Subcutaneous Rybrevant in NSCLC
Compare JNJ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JNJ Johnson & Johnson - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.